Skip to main content
SpringerLink
Log in

The Role of Enteric Infection and the Microbiome in Human Health and Disease

  • Chapter
  • First Online:
Clinical Understanding of the Human Gut Microbiome

  • 147 Accesses

Abstract

One of the many benefits the gut microbial community provides to the human host is protection against infection by external pathogens (colonization resistance). Strategies to bolster this protective effect may have important implications both in the developing world, where diseases of the gastrointestinal tract still represent significant healthcare problems, and for combating food-borne and travel-associated illnesses in more developed countries. Potential strategies have included promoting overall microbiome health and the populations of ‘good’ microbes (primarily bacteria and yeast) using probiotics and prebiotics, but thus far there is little evidence that these can have a clinically significant effect in the prevention or treatment of disease. However, certain levels of exposure to food-borne and environmental microbes, particularly early in life, appear essential for innate and adaptive immune development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, et al. World Health Organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001920.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, et al. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001921.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Glaesser D, Kester J, Paulose H, Alizadeh A, Valentin B. Global travel patterns: an overview. J Travel Med. 2017;24(4).

    Google Scholar 

  4. Helander HF, Fandriks L. Surface area of the digestive tract—revisited. Scand J Gastroenterol. 2014;49(6):681–9.

    Article  PubMed  Google Scholar 

  5. Macfarlane S, Bahrami B, Macfarlane GT. Mucosal biofilm communities in the human intestinal tract. Adv Appl Microbiol. 2011;75:111–43.

    Article  CAS  PubMed  Google Scholar 

  6. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336(6086):1268–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bohnhoff M, Miller CP. Enhanced susceptibility to Salmonella infection in streptomycin-treated mice. J Infect Dis. 1962;111:117–27.

    Article  CAS  PubMed  Google Scholar 

  8. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol. 2013;14(7):685–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Leslie JL, Young VB. The rest of the story: the microbiome and gastrointestinal infections. Curr Opin Microbiol. 2015;23:121–5.

    Article  CAS  PubMed  Google Scholar 

  10. Ducarmon QR, Zwittink RD, Hornung BVH, van Schaik W, Young VB, Kuijper EJ. Gut microbiota and colonization resistance against bacterial enteric infection. Microbiol Mol Biol Rev. 2019;83(3):e00007-19.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Roberfroid MB. Prebiotics and probiotics: are they functional foods? Am J Clin Nutr. 2000;71(6 Suppl):1682S–7S; discussion 8S–90S.

    Article  CAS  PubMed  Google Scholar 

  12. Dunne C, O’Mahoney L, Murphy L. In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001;73:3865–925.

    Article  Google Scholar 

  13. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17(2):259–75.

    Article  CAS  PubMed  Google Scholar 

  14. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6(6):374–82.

    Article  PubMed  Google Scholar 

  15. McFarland LV. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med Infect Dis. 2007;5(2):97–105.

    Article  PubMed  Google Scholar 

  16. Kollaritsch H, Holst H, Grobara P, Wiedermann G. Prevention of travelers’ diarrhea with Saccharomyces boulardii: results of a placebo controlled double-blind study. Fortschr Med. 1993;111(9):152–6.

    CAS  PubMed  Google Scholar 

  17. Kollaritsch HH, Wiedermann G. Prevention of traveler’s diarrhea: a double-blind randomized trial with Saccharomyces cerevisiae Hansen CBS 5926. Travel medicine. Berlin: Springer Science + Business Media; 1989. p. 328–32.

    Google Scholar 

  18. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, et al. Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann Med. 1990;22(1):53–6.

    Article  CAS  PubMed  Google Scholar 

  19. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med. 1997;4(1):41–3.

    Article  CAS  PubMed  Google Scholar 

  20. Drakoularakou A, Tzortzis G, Rastall RA, Gibson GR. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers’ diarrhoea. Eur J Clin Nutr. 2010;64(2):146–52.

    Article  CAS  PubMed  Google Scholar 

  21. Tzortzis G. Development and functional properties of Bimuno®: a second-generation prebiotic mixture. Food Sci Technol Bull Funct Foods. 2010;6(7):81–9.

    Article  Google Scholar 

  22. Hasle G, Raastad R, Bjune G, Jenum PA, Heier L. Can a galacto-oligosaccharide reduce the risk of traveller’s diarrhoea? A placebo-controlled, randomized, double-blind study. J Travel Med. 2017;24(5).

    Google Scholar 

  23. Krokowicz L, Kaczmarek BF, Krokowicz P, Stojcev Z, Mackiewicz J, Walkowiak J, et al. Sodium butyrate and short chain fatty acids in prevention of travellers’ diarrhoea: a randomized prospective study. Travel Med Infect Dis. 2014;12(2):183–8.

    Article  PubMed  Google Scholar 

  24. Power SE, O’Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr. 2014;111(3):387–402.

    Article  CAS  PubMed  Google Scholar 

  25. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;2010(11):CD003048.

    PubMed  PubMed Central  Google Scholar 

  26. Bruno F, Frigerio G. [A new therapeutic alternative for the treatment of enteritis—controlled double-blind tests with the strain SF 68]. Schweiz Rundsch Med Prax. 1981;70(39):1717–20.

    Google Scholar 

  27. Bruno F, Nastasi A, Bruno M. [Double-blind controlled study of the effect of the lactogenic enterococcus SF68 strain on various enterocolitis associated manifestations and on Salmonella infections]. Clin Ter. 1983;105(3):203–7.

    Google Scholar 

  28. Buydens P, Debeuckelaere S. Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial. Scand J Gastroenterol. 1996;31(9):887–91.

    Article  CAS  PubMed  Google Scholar 

  29. Wunderlich PF, Braun L, Fumagalli I, D’Apuzzo V, Heim F, Karly M, et al. Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea. J Int Med Res. 1989;17(4):333–8.

    Article  CAS  PubMed  Google Scholar 

  30. Mitra AK, Rabbani GH. A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli. Gastroenterology. 1990;99(4):1149–52.

    Article  CAS  PubMed  Google Scholar 

  31. Höchter W, Chase D, Hagenhoff G. Saccharomyces boulardii in the treatment of acute adult diarrhoea. [Saccharomyces boulardii bei acuter Erwachsenendiarrhoea]. Münchener medizinische Wochenschrift. 1990;132(12):188–92.

    Google Scholar 

  32. Lund B, Edlund C. Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin Infect Dis. 2001;32(9):1384–5.

    Article  CAS  PubMed  Google Scholar 

  33. Noguera T, Wotring R, Melville CR, Hargraves K, Kumm J, Morton JM. Resolution of acute gastroenteritis symptoms in children and adults treated with a novel polyphenol-based prebiotic. World J Gastroenterol. 2014;20(34):12301–7.

    Article  PubMed  PubMed Central  Google Scholar 

  34. David LA, Weil A, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, et al. Gut microbial succession follows acute secretory diarrhea in humans. mBio. 2015;6(3):e00381-15.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kampmann C, Dicksved J, Engstrand L, Rautelin H. Composition of human faecal microbiota in resistance to Campylobacter infection. Clin Microbiol Infect. 2016;22(1):61.e1–8.

    Article  CAS  PubMed  Google Scholar 

  36. Dicksved J, Ellstrom P, Engstrand L, Rautelin H. Susceptibility to Campylobacter infection is associated with the species composition of the human fecal microbiota. mBio. 2014;5(5):e01212-14.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Nelson AM, Walk ST, Taube S, Taniuchi M, Houpt ER, Wobus CE, et al. Disruption of the human gut microbiota following Norovirus infection. PLoS One. 2012;7(10):e48224.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Connor BA, Riddle MS. Post-infectious sequelae of travelers’ diarrhea. J Travel Med. 2013;20(5):303–12.

    Article  PubMed  Google Scholar 

  39. Hurst AF, Barber HW, Knott FA, Ross TA. Medical diseases of war. Arnold; 1944.

    Google Scholar 

  40. Chaudhary NA, Truelove SC. The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med. 1962;31:307–22.

    CAS  PubMed  Google Scholar 

  41. Stewart GT. Post-dysenteric colitis. Br Med J. 1950;1(4650):405–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Schwille-Kiuntke J, Mazurak N, Enck P. Systematic review with meta-analysis: post-infectious irritable bowel syndrome after travellers’ diarrhoea. Aliment Pharmacol Ther. 2015;41(11):1029–37.

    Article  CAS  PubMed  Google Scholar 

  43. Halvorson HA, Schlett CW, Riddle MS. Post-infectious irritable bowel syndrome—a meta-analysis. Am J Gastroenterol. 2006;101:1894–9.

    Article  PubMed  Google Scholar 

  44. Deising A, Gutierrez RL, Porter CK, Riddle MS. Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas. Gastroenterol Hepatol (N Y). 2013;9(3):145–57.

    PubMed  Google Scholar 

  45. Morabia A. Until the lab takes it away from epidemiology. Prev Med. 2011;53(4–5):217–20.

    Article  PubMed  Google Scholar 

  46. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41(12):850–3.

    Article  CAS  PubMed  Google Scholar 

  47. Rutella S, Locatelli F. Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 2011;17(33):3761–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Wells JM, Rossi O, Meijerink M, van Baarlen P. Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci U S A. 2011;108(Suppl 1):4607–14.

    Article  CAS  PubMed  Google Scholar 

  49. Fukudo S, Kanazawa M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26(Suppl 3):110–5.

    Article  CAS  PubMed  Google Scholar 

  50. Mearin F, Perello A, Balboa A, Perona M, Sans M, Salas A, et al. Pathogenic mechanisms of postinfectious functional gastrointestinal disorders: results 3 years after gastroenteritis. Scand J Gastroenterol. 2009;44(10):1173–85.

    Article  CAS  PubMed  Google Scholar 

  51. Jung IS, Kim HS, Park H, Lee SL. The clinical course of post-infectious irritable bowel syndrome: a five-year follow-up study. J Clin Gastroenterol. 2009;43:534–40.

    Article  PubMed  Google Scholar 

  52. Verdu EF, Riddle MS. Chronic gastrointestinal consequences of acute infectious diarrhea: evolving concepts in epidemiology and pathogenesis. Am J Gastroenterol. 2012;107(7):981–9.

    Article  PubMed  Google Scholar 

  53. Bashashati M, Rezaei N, Andrews CN, Chen CQ, Daryani NE, Sharkey KA, et al. Cytokines and irritable bowel syndrome: where do we stand? Cytokine. 2012;57(2):201–9.

    Article  CAS  PubMed  Google Scholar 

  54. Rajilic-Stojanovic M, Biagi E, Heilig HG, Kajander K, Kekkonen RA, Tims S, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141(5):1792–801.

    Article  CAS  PubMed  Google Scholar 

  55. Talley NJ, Fodor AA. Bugs, stool, and the irritable bowel syndrome: too much is as bad as too little? Gastroenterology. 2011;141(5):1555–9.

    Article  PubMed  Google Scholar 

  56. Jalanka-Tuovinen J, Salojarvi J, Salonen A, Immonen O, Garsed K, Kelly FM, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2013;63:1737–45.

    Article  PubMed  Google Scholar 

  57. Kalischuk LD, Leggett F, Inglis GD. Campylobacter jejuni induces transcytosis of commensal bacteria across the intestinal epithelium through M-like cells. Gut Pathog. 2010;2:14.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, Pepper M, et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science. 2012;337(6101):1553–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Pimentel M, Morales W, Pokkunuri V, Brikos C, Kim SM, Kim SE, et al. Autoimmunity links vinculin to the pathophysiology of chronic functional bowel changes following Campylobacter jejuni infection in a rat model. Dig Dis Sci. 2015;60(5):1195–205.

    Article  CAS  PubMed  Google Scholar 

  60. Pokkunuri V, Pimentel M, Morales W, Jee SR, Alpern J, Weitsman S, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motil. 2012;18(4):434–42.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Morales W, Pimentel M, Hwang L, Kunkel D, Pokkunuri V, Basseri B, et al. Acute and chronic histological changes of the small bowel secondary to C. jejuni infection in a rat model for post-infectious IBS. Dig Dis Sci. 2011;56(9):2575–84.

    Article  PubMed  Google Scholar 

  62. Pimentel M, Morales W, Jee SR, Low K, Hwang L, Pokkunuri V, et al. Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS. Dig Dis Sci. 2011;56(7):1962–6.

    Article  CAS  PubMed  Google Scholar 

  63. Pimentel M, Chatterjee S, Chang C, Low K, Song Y, Liu C, et al. A new rat model links two contemporary theories in irritable bowel syndrome. Dig Dis Sci. 2008;53(4):982–9.

    Article  PubMed  Google Scholar 

  64. Pike BL, Paden KA, Alcala AN, Jaep KM, Gormley RP, Maue AC, et al. Immunological biomarkers in postinfectious irritable bowel syndrome. J Travel Med. 2015;22(4):242–50.

    Article  PubMed  Google Scholar 

  65. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax. 2000;55 Suppl 1(Suppl 1):S2–10.

    Article  CAS  PubMed  Google Scholar 

  67. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med. 2002;347(12):911–20.

    Article  PubMed  Google Scholar 

  68. Bloomfield SF, Rook GA, Scott EA, Shanahan F, Stanwell-Smith R, Turner P. Time to abandon the hygiene hypothesis: new perspectives on allergic disease, the human microbiome, infectious disease prevention and the role of targeted hygiene. Perspect Public Health. 2016;136(4):213–24.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Rook GA. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Darwinian medicine and the ‘hygiene’ or ‘old friends’ hypothesis. Clin Exp Immunol. 2010;160(1):70–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Alexandre-Silva GM, Brito-Souza PA, Oliveira ACS, Cerni FA, Zottich U, Pucca MB. The hygiene hypothesis at a glance: early exposures, immune mechanism and novel therapies. Acta Trop. 2018;188:16–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Nevada, Reno School of Medicine, Reno, NV, USA

    Mark S. Riddle

Authors
  1. Mark S. Riddle
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, West Hollywood, CA, USA

    Mark Pimentel

  2. Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, West Hollywood, CA, USA

    Ruchi Mathur

  3. Medically Associated Science and Technology (MAST) Program, Cedars-Sinai Medical Center, West Hollywood, CA, USA

    Gillian M. Barlow

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Riddle, M.S. (2023). The Role of Enteric Infection and the Microbiome in Human Health and Disease. In: Pimentel, M., Mathur, R., Barlow, G.M. (eds) Clinical Understanding of the Human Gut Microbiome. Springer, Cham. https://doi.org/10.1007/978-3-031-46712-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-46712-7_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-46711-0

  • Online ISBN: 978-3-031-46712-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation